Hypertension (High Blood Pressure) News and Research

RSS

Hypertension (or high blood pressure) is a condition where the pressure of the blood flowing through the arteries of the body is higher than it should be. Much like the pressure of the air in a tire, if the pressure of the blood is too high it can damage the arteries and organs of the body. Just like the tire, if the pressure suddenly becomes very high, catastrophic events can happen. Similarly, if the pressure remains somewhat elevated for a long enough period of time, premature wear and failure can occur.

Hypertension has its worst effects on the heart, kidneys, eyes, and brain. High blood pressure is a risk factor for heart attack, stroke, kidney failure, hemorrhages of the retina of the eye, and generalized atherosclerosis (hardening of the arteries all over the body).

Higher intake of lycopene may lower risk of renal cell carcinoma in postmenopausal women

A higher intake by postmenopausal women of the natural antioxidant lycopene, found in foods like tomatoes, watermelon and papaya, may lower the risk of renal cell carcinoma, a type of kidney cancer.

2 Mar 2015

Kyprolis demonstrates superiority over velcade in patients with relapsed multiple myeloma in head-to-head endeavor trial

Patients Receiving Kyprolis Lived Twice as Long without Disease Progression

2 Mar 2015

Researchers successfully convert adult human skin cells into neurons that control appetite

Researchers have for the first time successfully converted adult human skin cells into neurons of the type that regulate appetite, providing a patient-specific model for studying the neurophysiology of weight control and testing new therapies for obesity.

28 Feb 2015

Young women veterans referred for cardiac tests more likely to be depressed than men veterans

Women veterans who had specialized heart tests were younger and more likely to be obese, depressed and suffer from post-traumatic stress disorder than men veterans, according to a study published in an American Heart Association journal.

27 Feb 2015

Patients with symptoms of mental illness less likely to receive advice from health care providers

More than half of patients with symptoms of mental illness - and nearly one-third of those who also had diabetes - said their health care providers had never told them to exercise or reduce their intake of dietary fat, according to a new study published in Diabetes Educator.

25 Feb 2015

'Walking football' could have a multitude of health benefits, say researchers

The new sporting craze of 'Walking Football' may enable people to continue playing football into their 60s and 70s while reaping a multitude of health benefits, according to Aston University researchers.

25 Feb 2015

Two widely used targeted therapy drugs not effective in preventing return of kidney cancer

Two widely used targeted therapy drugs— approved by the FDA for use in metastatic kidney cancer —are no more effective than a placebo in preventing return of the disease to increase life spans of patients suffering from advanced kidney cancer after surgery, according to new results to be presented by a researcher at the University of Pennsylvania's Abramson Cancer Center during the 2015 Genitourinary Cancers Symposium.

24 Feb 2015

Penn State researchers explore hydrogen sulfide's probable role in regulating blood pressure

Widely considered simply a malodorous toxic gas, hydrogen sulfide is now being studied for its probable role in regulating blood pressure, according to researchers.

20 Feb 2015

Large majority of coronary patients fail to meet lifestyle, risk factor targets

The large majority of coronary patients in Europe are failing to achieve their lifestyle, risk factor and therapeutic targets as set out in the latest prevention guidelines.

17 Feb 2015

Research finding could lead to new therapeutic target for treating hypertension in males

Higher levels of a "danger" molecule may be one reason males tend to become hypertensive earlier and more severely than females, scientists say.

16 Feb 2015

$Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC$

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Eisai Inc. announced today that the U.S. Food and Drug Administration approved the company's receptor tyrosine kinase inhibitor LENVIMA (lenvatinib) for the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC).

13 Feb 2015

PAH survival unaffected by rheumatoid arthritis origin

Patients with rheumatoid arthritis-associated pulmonary arterial hypertension have comparable survival to those with idiopathic pulmonary arterial hypertension, researchers report.

13 Feb 2015

Radionuclide angiography-assessed RVEF predicts PAH outcomes

Baseline right ventricular ejection fraction as evaluated by conventional planar equilibrium radionuclide angiography is significantly associated with outcomes in patients with pulmonary arterial hypertension, research suggests.

13 Feb 2015

Mechanistic subtypes of IPAH revealed

Researchers have provided evidence for distinct processes underlying vasodilator-responsive and nonresponsive idiopathic pulmonary arterial hypertension.

13 Feb 2015

Retinal function affected early in Type 1, 2 diabetes

Visual dysfunction manifests early in Type 1 and Type 2 diabetes, research shows, with functional impairment detected in patients with nonproliferative diabetic retinopathy lacking clinical signs and symptoms of diabetic macular oedema.

13 Feb 2015

Lenvatinib trial offers hope for thyroid cancer patients

A new targeted therapy called lenvatinib has been shown to improve progression-free survival among patients with advanced thyroid cancer that is not responsive to iodine-131.

13 Feb 2015

Scientists find that treating the uninjured side of brain can maximize stroke recovery

To maximize stroke recovery, researchers may want to focus more on ways to support the side of the brain where the injury didn't occur, scientists report.

13 Feb 2015

$Lenvatinib therapy improves survival in patients with advanced radioiodine-refractory thyroid cancer$

Lenvatinib therapy improves survival in patients with advanced radioiodine-refractory thyroid cancer

In a pivotal Phase III study led by researchers at The University of Texas MD Anderson Cancer Center, the oral anti-angiogenic therapy lenvatinib has shown dramatic improvement in progression-free survival in patients with advanced radioiodine-refractory thyroid cancer.

12 Feb 2015

Despite growing shortage of donor hearts, surgeons, transplant centers reject marginal hearts

Surgeons and transplant centers nationwide increasingly have rejected hearts donated for transplantation despite a growing need for them, according to a new study by researchers at the Stanford University School of Medicine.

12 Feb 2015

Blood pressure-lowering treatment lowers CVD, heart disease risks among type 2 diabetes patients

Blood pressure-lowering treatment among patients with type 2 diabetes is associated with a lower risk of cardiovascular disease (CVD) and heart disease events and improved mortality, according to a study in the February 10 issue of JAMA.

11 Feb 2015

Hypertension (High Blood Pressure) News and Research

Further Reading

Higher intake of lycopene may lower risk of renal cell carcinoma in postmenopausal women

Kyprolis demonstrates superiority over velcade in patients with relapsed multiple myeloma in head-to-head endeavor trial

Researchers successfully convert adult human skin cells into neurons that control appetite

Young women veterans referred for cardiac tests more likely to be depressed than men veterans

Patients with symptoms of mental illness less likely to receive advice from health care providers

'Walking football' could have a multitude of health benefits, say researchers

Two widely used targeted therapy drugs not effective in preventing return of kidney cancer

Penn State researchers explore hydrogen sulfide's probable role in regulating blood pressure

Large majority of coronary patients fail to meet lifestyle, risk factor targets

Research finding could lead to new therapeutic target for treating hypertension in males

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

PAH survival unaffected by rheumatoid arthritis origin

Radionuclide angiography-assessed RVEF predicts PAH outcomes

Mechanistic subtypes of IPAH revealed

Retinal function affected early in Type 1, 2 diabetes

Lenvatinib trial offers hope for thyroid cancer patients

Scientists find that treating the uninjured side of brain can maximize stroke recovery

Lenvatinib therapy improves survival in patients with advanced radioiodine-refractory thyroid cancer

Despite growing shortage of donor hearts, surgeons, transplant centers reject marginal hearts

Blood pressure-lowering treatment lowers CVD, heart disease risks among type 2 diabetes patients

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News